Certificate of Analysis (COA) View the laboratory certificate for this product [ View COA ]

Dex Pharma Tirz Max Pen - 60mg/3mL

R 2,890.00 R 2,690.00
Add to WishlistCompare

Dex Pharma Tirz Max Pen 60mg/3mL — Research-Grade Tirzepatide Pen

Dex Pharma Tirz Max Pen 60mg/3mL is a high-strength tirzepatide research product supplied in a 3mL pen format for controlled laboratory and scientific research applications.

The presentation contains a defined 60mg total quantity of tirzepatide research material in a convenient pen format. The product is positioned within metabolic and peptide research, with tirzepatide studied for its activity across GIP and GLP-1 receptor pathways.

This product is supplied strictly for research purposes and is not intended for human consumption, self-administration, diagnosis, treatment, prevention or veterinary use.

Research Overview

Tirzepatide is a synthetic peptide investigated for its interaction with both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor pathways.

Laboratory and scientific research into tirzepatide includes investigation of receptor signalling, metabolic pathways, peptide-receptor interactions and related biochemical mechanisms.

Product Information

• Product: Dex Pharma Tirz Max Pen
• Active compound: Tirzepatide
• Total quantity: 60mg
• Volume: 3mL
• Format: Research pen
• Supplier/Brand: Dex Pharma
• Product vendor: Xander
• Research category: Metabolic Research
• Intended use: Laboratory research only

Research Areas

Tirzepatide may be of interest to researchers investigating:

• GIP receptor signalling
• GLP-1 receptor signalling
• Metabolic research
• Peptide-receptor interactions
• Cellular signalling
• Biochemical research
• Metabolic pathway research

Research Context

Tirzepatide is widely studied as a dual GIP and GLP-1 receptor agonist. Research findings should be interpreted within the context of the relevant scientific literature and should not be treated as evidence of clinical efficacy for this research product.

Research-Use Notice

This product is supplied strictly for laboratory and scientific research purposes. It is not intended for human consumption, self-administration, diagnosis, treatment, prevention or veterinary use.

Key Features

• Dex Pharma Tirz Max Pen 60mg/3mL
• Tirzepatide research product
• 60mg total research presentation
• 3mL pen format
• Research interest includes GIP and GLP-1 receptor pathways
• Suitable for controlled laboratory and scientific research
• Metabolic research application
• Supplied by Xander
• Research use only

Dosage & Usage

Tirzepatide is a synthetic dual GIP and GLP-1 receptor agonist investigated in scientific literature relating to metabolic signalling, receptor pharmacology, peptide biology and related biochemical pathways. This information is provided for general research context and should not be interpreted as evidence of clinical efficacy for this specific product. Product identity, purity and batch-specific analytical information should be verified against the applicable Certificate of Analysis.

FAQ's & Tips

What is Dex Pharma Tirz Max Pen 60mg/3mL?
Dex Pharma Tirz Max Pen 60mg/3mL is a tirzepatide research product supplied in a 3mL pen format containing a defined 60mg total research presentation.

What is tirzepatide?
Tirzepatide is a synthetic peptide investigated for its activity at both GIP and GLP-1 receptor pathways.

What is the research focus of tirzepatide?
Research includes GIP and GLP-1 receptor signalling, metabolic pathways, peptide-receptor interactions and related biochemical mechanisms.

What format is Tirz Max supplied in?
This product is supplied in a 3mL research pen format with a stated total quantity of 60mg.

What research category does this product belong to?
Tirz Max is classified within metabolic and peptide research.

Is this product intended for human use?
No. This product is supplied strictly for laboratory and scientific research purposes and is not intended for human or veterinary use.

Where can I find analytical information?
Refer to the applicable batch-specific Certificate of Analysis where available.

What is the difference between this and lower-strength tirzepatide research products?
The key product difference is the stated total quantity of research material and presentation format. Researchers should evaluate products based on their documented specifications and intended experimental requirements.

Research

Tirzepatide is a synthetic peptide investigated for activity across GIP and GLP-1 receptor pathways. Research includes investigation of receptor signalling, metabolic pathways, peptide-receptor interactions and related biochemical mechanisms under controlled experimental conditions.

Reviews